Related Articles

• The anti-leukemic effect and molecular mechanisms of novel hydroxamate and benzamide histone deacetylase inhibitors with 5-aza-cytidine
• Mechanisms and potential molecular markers of early response to combination epigenetic therapy in patients with myeloid malignancies
• Epigenetic treatment‑mediated modulation of PD‑L1 predicts potential therapy resistance over response markers in myeloid malignancies: A molecular mechanism involving effectors of PD‑L1 reverse signaling
• A novel combination of oridonin and valproic acid in enhancement of apoptosis induction of HL-60 leukemia cells
• The epigenetic agents suberoylanilide hydroxamic acid and 5‑AZA‑2' deoxycytidine decrease cell proliferation, induce cell death and delay the growth of MiaPaCa2 pancreatic cancer cells in vivo